SKN | Tarsier Pharma Increases IPO Size by 11% Ahead of $50 Million NYSE Listing
Tarsier Pharma has increased the size of its upcoming initial public offering (IPO), signaling stronger fundraising ambitions as it prepares to enter the U.S....
SKN | Braveheart Bio Files for $100 Million IPO to Advance Phase 3 Cardiovascular Drug Development
Braveheart Bio has filed for an initial public offering (IPO) seeking to raise up to $100 million as it prepares to advance its lead...
SKN | KraneShares Trust Eyes Market Debut as New ETF Offering Expands Investor Access to Thematic Strategies
KraneShares Trust is preparing to launch a new exchange-traded fund (ETF), adding to its growing lineup of thematic and globally focused investment products. The...
SKN | Jones Ventures INTL Acquisition1 Prices $200 Million SPAC IPO to Target High-Growth Industries
Jones Ventures INTL Acquisition1 has successfully priced its $200 million IPO, joining the growing pipeline of special purpose acquisition companies seeking opportunities in innovative...
SKN | Attovia Therapeutics Files for $100 Million IPO to Advance Pipeline for Immune-Mediated Diseases
Key Points:
• Attovia Therapeutics has filed with the U.S. Securities and Exchange Commission (SEC) to raise up to $100 million through an initial public...